Correction to Drug Study Halted Early Article
April 27 2020 - 11:12AM
Dow Jones News
George D. Yancopoulos is the chief scientific officer of
Regeneron Pharmaceuticals. "Drug Study Halted Early for Certain
Covid-19 Patients After No Benefit Seen," at 7 a.m. ET on April 27,
incorrectly said he was the company's chief medical officer.
(END) Dow Jones Newswires
April 27, 2020 10:57 ET (14:57 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sanofi (EU:SAN)
Historical Stock Chart
From Sep 2023 to Sep 2024